Patient P-01737
Synthetic patientNBL-101 · Day 117 · 55–64 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S14
- Day 44 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 44.
Primary contributors, last 14 days
- Treatment adherence-7
- GI instability-6
- Toxicity+5
- Nutritional resilience-2
What helped?
No interventions yet.
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 83% showed improvement
- median effect visible after 8 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion62.7/100
stable · -0.6 vs previous 14 d
Toxicity
Blood55.3/100
stable · +2.0 vs previous 14 d
Sleep quality
Wearable5.5/100
improving · +1.2 vs previous 14 d
Energy level
Daily log1.5/10
improving · +0.2 vs previous 14 d
Stress level
Daily log8/10
stable · +0.0 vs previous 14 d
Steps
Wearable5,303
stable · +17 vs previous 14 d
Adherence
Companion36.1 %
stable · -0.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 10 from the failing basin, 78 from restoration.
Would help
Would not help
- Keep simple carbs lowGI +2.7 next day on high-intake days · n 18
- Keep fibre lowGI +2.6 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+2.7detractor · 93%
- Insoluble fibre+2.6detractor · 81%
- Histamine load-0.8no signal · 19%
- Dietary fat load+0.6no signal · 17%
- Spicy / capsaicin+0.5no signal · 15%
- Alcohol+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓60
- MicrobiomeAkkermansia low → thinner mucus layer
- Daily logGI symptom score 63 and rising
- WearableSleep 5.4 h, below personal baseline
- Inflammatory signalling ↑60
- MicrobiomeBacteroides fragilis expansion
- BloodInflammatory load index 62
- WearableHRV 19 ms, trending down
- Butyrate / short-chain fatty acid production ↓45
- MicrobiomeF. prausnitzii depleted
- Daily logFibre intake low in recent food logs
- Drug metabolism and exposure ↑20
- BloodToxicity index 55
- Autonomic recovery ↑20
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 1.8 · butyrate capacity 46/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 15 ms
- Sleep
- 5.9 h
- Steps
- 5,586
- Resting HR
- 70 bpm
Daily log: GI score 63, nutritional resilience 32, adherence 36.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01655 | 55% | S14 | GI-04 | no change | 29 |
| P-01760 | 48% | S14 | — | — | 42 |
| P-01813 | 47% | S01 | NP-02 | no change | 40 |
| P-01605 | 46% | S14 | ME-01 | improved | 41 |
| P-01619 | 46% | S14 | GI-04 | worsened | 38 |
| P-01866 | 46% | S14 | — | — | 40 |
| P-01797 | 45% | S14 | NP-02 | no change | 43 |
| P-01407 | 44% | S14 | NP-02 | no change | 44 |
| P-01762 | 44% | S14 | NP-02 | no change | 40 |
| P-01776 | 44% | S16 | NP-02 | no change | 47 |
| P-01564 | 43% | S14 | ME-01 | improved | 39 |
| P-01582 | 43% | S14 | GI-04 | no change | 45 |